Pediatric Provider Experiences With Single Maintenance and Reliever Therapy (SMART)

Nancy Byatt has received salary and/or funding support from Massachusetts Department of Mental Health via the Massachusetts Child Psychiatry Access Program for Moms (MCPAP for Moms). She is also the Medical Director of Research and Evaluation for MCPAP for Moms and the Executive Director of the Lifeline for Families Center at UMass Chan Medical School. She has served as a consultant for The Kinetix Group, VentureWell, and JBS International. James G. Krings reports grants/funding from the NIH, ALA, PCORI, Doris Duke Charitable Foundation, AstraZeneca, Genentech/Roche, GSK, Areteia Therapeutics, Sound Pharmaceuticals, Connect Biopharma, Pfizer, and Sanofi/Regeneron; and consulting fees/honoraria from Genentech, Chiesi USA, Apogee Therapeutics, AstraZeneca, Aerogen, Sanofi/Regeneron, Guidepoint, and Frazier Life Sciences. Jerry A. Krishnan reports grants from National Institutes of Health, American Lung Association, BioVie Pharma, COPD Foundation, Patient Centered Outcomes Research Institute, and Sanofie/Regeneron outside the submitted work; personal fees from American Academy of Allergy, Asthma, and Immunology, American Board of Internal Medicine, AstraZeneca, DynaMed/EBSCO, Genentech, Inogen, MedImmune, RespirAI, and Verona Pharma; and he is a member of the Board of Directors for the Global Initiative of Asthma (GINA), though this work represents his personal views, and not of GINA. The remaining authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.